Camlin Fine Sciences promoters declare no encumbrance on shares for FY26

1 min read     Updated on 08 Jul 2026, 08:11 AM
scanx
Reviewed by
Riya DScanX News Team
AI Summary

Camlin Fine Sciences Ltd disclosed that its promoters and promoter group have not created any encumbrance on shares held by them during the financial year ended March 31, 2026. The declaration, submitted by Ashish Dandekar, was made pursuant to Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The filing covers eight entities, including individuals and corporate bodies, and was submitted to NSE, BSE, and the company's Audit Committee.

powered bylight_fuzz_icon
45024062

*this image is generated using AI for illustrative purposes only.

Camlin Fine Sciences Ltd disclosed that its promoters and promoter group have not created any encumbrance on the shares held by them during the financial year ended March 31, 2026. This declaration was submitted to the stock exchanges to confirm compliance with regulatory norms regarding share holdings.

The disclosure was made pursuant to Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. Ashish Dandekar submitted the declaration on behalf of the promoter group, confirming that no new encumbrances were made other than those already disclosed.

The filing identifies the specific entities and individuals covered under this declaration. The list includes individual promoters as well as corporate entities within the group.

Name of Entity Person Category
Ashish S Dandekar Promoter
Radha Pandit Promoter Group
Anand Y Pandit Promoter Group
Anagha Dandekar Promoter
Vibha Agencies Pvt Ltd Promoter
Camart Finance Ltd Promoter
Cafco Consultants Ltd Promoter
MK Falcon Agrotech Pvt Ltd Promoter

The letter was addressed to the National Stock Exchange of India Ltd, BSE Limited, and the Audit Committee of Camlin Fine Sciences Ltd. The company requested that the information be disseminated on the websites of the exchanges.

Historical Stock Returns for Camlin Fine Sciences

1 Day5 Days1 Month6 Months1 Year5 Years
-0.59%-5.68%-3.40%-15.89%-57.62%-36.60%

Does the absence of new encumbrances indicate a shift in the promoter group's strategy toward reducing leverage or funding requirements?

How might this clean declaration of holdings influence investor confidence and stock liquidity in the upcoming quarters?

Are there any upcoming corporate actions or capital expenditure plans that might require the promoters to leverage their shares in the future?

Camlin Fine Sciences holds analyst meeting in Mumbai

1 min read     Updated on 02 Jul 2026, 06:17 PM
scanx
Reviewed by
Jubin VScanX News Team
AI Summary

Camlin Fine Sciences Limited conducted a group meeting with investors and analysts on July 1, 2026, in Mumbai. The interaction, compliant with SEBI LODR regulations, focused on the company's performance and outlook using publicly available data. No unpublished price-sensitive information was disclosed during the session.

powered bylight_fuzz_icon
44191693

*this image is generated using AI for illustrative purposes only.

Camlin Fine Sciences Limited conducted a group meeting with investors and analysts on July 1, 2026, in Mumbai. The interaction, which commenced at 04:00 PM IST, aimed to engage stakeholders regarding the company's performance and outlook based on publicly available information. No unpublished price-sensitive information (UPSI) was disclosed during the session.

The meeting was held pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This regulation mandates timely disclosure of material events, including investor interactions, to ensure transparency with the stock exchanges. The company notified both BSE Limited and the National Stock Exchange of India Ltd. regarding the event.

Rahul Sawale, Company Secretary & VP Legal, confirmed the completion of the interaction in a filing dated July 1, 2026. The communication served as an update to the earlier intimation dated June 28, 2026, regarding the scheduling of the meeting.

Meeting Details

Date Time Details Location
July 1, 2026 04:00 PM IST Onwards Group Meeting Mumbai

The registered office of Camlin Fine Sciences Limited is located at Floor 2 to 5, In G.S. Point, CST Road, Kalina, Santacruz (East), Mumbai 400 098.

Historical Stock Returns for Camlin Fine Sciences

1 Day5 Days1 Month6 Months1 Year5 Years
-0.59%-5.68%-3.40%-15.89%-57.62%-36.60%

What key performance metrics did Camlin Fine Sciences highlight during the meeting?

How did analysts react to the company's future outlook presented in the session?

Are there any upcoming strategic initiatives or expansions discussed during the interaction?

More News on Camlin Fine Sciences

Must Read Next

Earnings

Corporate Actions

Stocks

1 Year Returns:-57.62%